Priya Kumar

Associate Partner & Gene Therapy Biosafety Officer (Consultant)

Priya Kumar received her Ph.D. from Postgraduate Institute of Medical Education & Research, Chandigarh, India. She did a second MS from Hunter College, NY in Environmental and Occupational Health Sciences. She worked as a Research Associate in New York Medical College, Valhalla. She changed her career from Research to Biosafety in 2000 and served at New York University Medical Center, Weill Cornell Medical Center, Lawrence Livermore National Labs and University of Washington as Biosafety Officer until her retirement in March, 2022. Priya enjoys yoga, traveling, long walks and listening to music. She remains interested in the field of biosafety and is excited to join Clinical Biosafety Services to serve as an Associate Partner Consultant.

Back to our Team

Get in touch with us to discuss IBC services for your clinical trials.

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.